Navigation Links
Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
Date:10/4/2007

HAYWARD, Calif., Oct. 4 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN) announced today that Robert G. Johnson, Jr., M.D., Ph.D., Kosan's President and CEO, will present at the BIO Investor Forum in San Francisco at the Palace Hotel on Thursday, October 11, 2007 at 11:30 a.m. Pacific Time. A live webcast of the presentation can be accessed through http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=KOSN&item_id=16576 63.

Interested parties may also access a live webcast of the presentation by visiting the "Events Calendar" page under the "Investors/Press" tab on Kosan's website at http://www.kosan.com. A recorded replay of the presentation will be available for two weeks.

About Kosan

Kosan Biosciences is a biotechnology company advancing two new classes of anticancer agents through clinical development -- Hsp90 (heat shock protein 90) inhibitors and epothilones. Kosan is leveraging its proprietary discovery platform to generate a pipeline of potentially significant product candidates, primarily in the area of oncology.

Hsp90 inhibitors have a novel mechanism of action targeting multiple pathways involved in cancer cell growth and survival. Tanespimycin (KOS-953) is being tested in combination with bortezomib (Velcade(R)) in patients with multiple myeloma in a registration program called TIME. Tanespimycin is also being studied in HER2-positive metastatic breast cancer in combination with trastuzumab (Herceptin(R)), and as monotherapy in metastatic melanoma. Intravenous and oral formulations of Kosan's second-generat
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 The new , Healthcare and ... available today on PharmaBoardroom.com for free download ... rocked the Spanish economy in 2009, and the austerity measures ... remained pragmatic in times of trouble. "Despite the ... biggest European market, and the general conditions to invest are ...
(Date:9/18/2014)... 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 Deep Research ... and "2014 Deep Research Report on Global and ... database. Photo - http://photos.prnewswire.com/prnh/20140918/147058 ... Global and China Acetic Acid Industry" is a ... China and Global Acetic Acid Market. ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Texas ... John Sharp, Texas A&M Health Science Center CEO ... Department of Health and Human Services (HHS), State ... a national pandemic influenza vaccine manufacturing facility in ... an anchor for the Texas A&M Biocorridor – ...
(Date:9/18/2014)... Research and Markets has announced ... Report 2014" report to their offering. ... a professional and in-depth study on the current state ... report provides a basic overview of the industry including ... albumin market analysis is provided for the international markets ...
Breaking Biology Technology:PharmaBoardroom Releases New Spain Pharmaceuticals Report 2PharmaBoardroom Releases New Spain Pharmaceuticals Report 3Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 2Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 3Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 4Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 3Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 4Global Human Albumin Industry Report 2014 2Global Human Albumin Industry Report 2014 3
... Xyrem(R) Net Sales Increase 34 Percent ... Scheduled for March 13, 2008, PALO ALTO, Calif., Feb. 13 ... for,the fourth quarter and full year ended December 31, 2007., ... compared to $12.4 million for the quarter ended December 31, 2006.,Total ...
... ... in America, FRANKLIN LAKES, N.J., ... driven by an aging,population, longer life expectancy and the development of exciting ... However, numerous national reports reveal a looming healthcare,crisis within the next decade ...
... - Dr. David L. Urdal, Dendreon Corporation, Joins Board ... Myers Appointed Vice ... VLST Corporation, a Seattle-based,biotechnology company focused on the development ... appointments of,Dr. David L. Urdal, chief scientific officer of ...
Cached Biology Technology:Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 2Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 3Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 4Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 5Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 6Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 7Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 8Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 9Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists 2Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists 3Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists 4VLST Corporation Announces Board and Executive Management Appointments 2VLST Corporation Announces Board and Executive Management Appointments 3
(Date:9/18/2014)... of researchers from McGill University and the Quebec ... polyethylene ,microbeads, Canadian Journal of Fisheries and ... from cosmetics, household cleansers, or industrial cleansers, to ... to their small size and buoyancy, they may ... are a global contaminant in the world,s oceans, ...
(Date:9/18/2014)... No matter how many times it,s demonstrated, ... communicating creatures. , But by using a ... radically alter their behavior to suit their population. ... them are present, and act accordingly. , Once ... it may change from innocuous to pathogenic, or ...
(Date:9/18/2014)... acquire and creatively manipulate spoken language is unique to ... 6 million years of human evolution to make this ... candidate gene we now have," says Wolfgang Enard, Professor ... efforts to understand the molecular biological basis of language ... results of his latest study, undertaken in collaboration with ...
Breaking Biology News(10 mins):Microplastic pollution discovered in St. Lawrence River sediments 2Researchers study vital 'on/off switches' that control when bacteria turn deadly 2Researchers study vital 'on/off switches' that control when bacteria turn deadly 3Language evolution: Quicker on the uptake 2Language evolution: Quicker on the uptake 3
... new evidence that biofilms bacteria that adhere to surfaces ... survival of the human pathogen Salmonella . One ... food each year, with over a million illnesses caused by ... Control and Prevention. Finding out what makes Salmonella ...
... Proteins are vital parts of living organisms, performing a ... reactions, and responding to stimuli. The complete set of ... under defined conditions, is known as the proteome. While ... proteome is remarkably dynamic, varying from cell to cell ...
... of cases, novel drugs tested on humans by pharmaceutical companies do ... drugs do not work, while at worst, test subjects die.,New research ... can be reduced. The secret is to test the drug on ... of 15 liver patients who participated in a medical trial following ...
Cached Biology News:Biofilms help Salmonella survive hostile conditions, Virginia Tech researchers say 2Metabolic fingerprinting: Using proteomics to identify proteins in gymnosperm pollination drops 2New cutting-edge cell research will lead to safer medical experiments on humans 2New cutting-edge cell research will lead to safer medical experiments on humans 3New cutting-edge cell research will lead to safer medical experiments on humans 4
... This DuoSet ELISA Development kit contains the ... sandwich ELISAs to measure natural and recombinant ... supernates and serum. Each kit contains sufficient ... 96-well plates, provided that the following conditions ...
E1A (adenovirus early region 1)...
Nucleobindin 1 [NUCB1]...
Syne-1 (N-19)...
Biology Products: